Global Animal Health Diagnosis Market
Description
MARKET SCOPE:
The global Animal Health Diagnosis market is projected to grow significantly, registering a CAGR of 9.4% during the forecast period (2024 – 2032).
Animal health diagnosis is the process of evaluating the health status of animals using diverse methods, techniques, and diagnostic tools. The primary objective is to identify and comprehend diseases, infections, or abnormalities affecting animals, allowing for the implementation of appropriate treatment and management strategies. This field is indispensable for preserving the well-being of livestock, pets, and wildlife.
Veterinarians play a pivotal role in this process by conducting physical examinations of animals to assess their overall health, identify symptoms, and detect any visible abnormalities. Additionally, diagnostic laboratories contribute significantly to animal health diagnosis by conducting a variety of tests on samples such as blood, urine, feces, tissues, or other biological materials. These tests encompass blood chemistry assessments, complete blood counts (CBC), serological tests, and microbiological cultures, among others. Such comprehensive diagnostic approaches are essential for effective veterinary care and the overall health management of animal populations.
MARKET OVERVIEW:
Driver: Growing awareness regarding animal health is driving the market growth.
The adoption of pets represents a noteworthy trend in the market. People are increasingly opting to bring pets into their homes, primarily for companionship, and there has been a significant shift in the perception of pet ownership towards considering individuals as pet parents rather than mere pet holders. According to the American Pet Products Association (APPA) in 2019, approximately 67% of households in the United States owned at least one pet. This substantial increase in the population of pet owners is serving as a key driver for the growth of the veterinary health market. As more individuals embrace the role of pet parents, there is a corresponding surge in the demand for veterinary services, healthcare products, and diagnostics to ensure the well-being of their animal companions. This shift in attitudes towards pets is influencing the dynamics of the veterinary health market, creating opportunities for growth and development in response to the evolving needs of pet owners.
Opportunities: Public-private partnerships for animal health is expected to pave the way for next generation optical fiber market growth in the upcoming years.
The increasing demand for animal care products is fueled by the reinforcement of public-private partnerships. Growing awareness and improved accessibility to these products are key contributors to the rising demand. The 2017 survey by the OIE-World Organization of Animal Health underscores the potential impact of Public-Private Partnerships (PPPs) in elevating the quality of veterinary services worldwide. This potential arises from the reorganization of dynamic and sustainable systems, ultimately making significant contributions to the health and well-being of human populations.
COVID IMPACT:
The animal diagnostics industry experienced a positive impact from the COVID-19 pandemic, with a significant increase in the adoption of pets and the use of animal diagnostic test kits. Despite this surge, temporary closures of veterinary units during lockdowns posed constraints in certain market segments. Notably, the demand for effective COVID-19 care for animals rose during this period, acknowledging their susceptibility to the disease. The University of Glasgow played a pioneering role in identifying the presence of COVID-19 infection among various pets, including cats, dogs, and other animals.
SEGMENTATION ANALYSIS:
The immunodiagnostics is anticipated to grow significantly during the forecast period.
The immunodiagnostics segment is anticipated to surpass USD 8 billion by 2032, driven by the increasing occurrences of zoonotic diseases in livestock. Common zoonoses affecting farm animals include viral respiratory tract infections, leptospirosis, bovine ephemeral fever, infectious bovine rhinotracheitis, and Johne's disease. According to the World Health Organization (WHO), approximately 1 billion cases of death and illness occur annually globally due to zoonoses. This underscores the critical need for advanced animal diagnostics among farmers to safeguard their investments in livestock. Immunodiagnostics plays a crucial role as it enables veterinarians to detect various autoimmune diseases, making it indispensable to the cause.
The hospital segment is anticipated to grow significantly during the forecast period.
In 2018, the largest share in the market was held by the hospitals & clinics segment. The growth of this segment was facilitated by the increasing number of pet hospitals and clinics, coupled with growing awareness about the spread of zoonotic diseases. Over the forecast period, the diagnostic centers segment is expected to experience rapid growth, driven by an increasing awareness among pet owners about the welfare and importance of preventive care for their companion animals. Furthermore, the market is being propelled by the introduction of molecular diagnostic tests such as ELISA and PCR, which now constitute a significant portion of animal healthcare practices. These advanced diagnostic techniques contribute to the overall expansion of the market.
REGIONAL ANALYSIS:
The North American region is set to witness significant growth during the forecast period.
In 2022, the North America market for animal diagnostics healthcare claimed the largest share, primarily attributed to various proactive measures implemented by government animal welfare organizations aimed at enhancing overall animal health. Additionally, the market in this region is expected to experience growth due to technological advancements, an elevated incidence of zoonotic diseases, and an increasing number of pet owners. Collaborative initiatives undertaken by major businesses to enhance their research and development capabilities and uphold high-quality standards are anticipated to further boost demand in the region. Moreover, the substantial share can be linked to the high disease burden prevalent in North America.
COMPETITIVE ANALYSIS:
The global Animal Health Diagnosis market is reasonably competitive with mergers, acquisitions, and product launches. See some of the major key players in the market.
Bimeda
In November 2023, Bimeda has opened a new manufacturing facility in China dedicated to sterile injections and parasite-control products, thereby expanding its operational capabilities.
Zoetis
In October 2023, Zoetis has initiated the commercial release of Librela, its anti-NGF monoclonal antibody treatment, in the United States for the management of pain associated with canine osteoarthritis.
Ceva Santé Animale
Merck & Co., Inc.
Vetoquinol S.A.
Boehringer Ingelheim Gmbh
Elanco
Virbac
Mars Inc.
Dechra Pharmaceuticals Plc
Idexx Laboratories, Inc.
SCOPE OF THE REPORT
By Technology
Immunodiagnostics
ELISA
Immunoassay Analyzers
Clinical Biochemistry
Glucose Monitoring
Hematology
Urinalysis
By Application
Parasitology
Pathology
By End Use
Clinics
Hospitals
By Region
North America (the United States & Canada)
Europe (Germany, UK, France, Spain, Italy, and the Rest of Europe)
Asia Pacific (China, Japan, India, and Rest of Asia Pacific)
Rest of the World (the Middle East & Africa, and Latin America)
KEY REASONS TO PURCHASE THIS REPORT
It provides a technological development map over time to understand the industry’s growth rate and indicates how the Animal Health Diagnosis market is evolving.
The report offers a dynamic method to various factors that drive or restrain the growth of the market and specifies which Animal Health Diagnosis submarket will be the main driver of the overall market from 2024 to 2032.
It renders a definite analysis of changing competitive dynamics and stipulates the leading players and what are their prospects over the forecast period.
It builds a nine-year estimate based on how the market is predicted to grow and shows what will market shares of the global region change by 2032 and which country will lead the market in 2032.
The global Animal Health Diagnosis market is projected to grow significantly, registering a CAGR of 9.4% during the forecast period (2024 – 2032).
Animal health diagnosis is the process of evaluating the health status of animals using diverse methods, techniques, and diagnostic tools. The primary objective is to identify and comprehend diseases, infections, or abnormalities affecting animals, allowing for the implementation of appropriate treatment and management strategies. This field is indispensable for preserving the well-being of livestock, pets, and wildlife.
Veterinarians play a pivotal role in this process by conducting physical examinations of animals to assess their overall health, identify symptoms, and detect any visible abnormalities. Additionally, diagnostic laboratories contribute significantly to animal health diagnosis by conducting a variety of tests on samples such as blood, urine, feces, tissues, or other biological materials. These tests encompass blood chemistry assessments, complete blood counts (CBC), serological tests, and microbiological cultures, among others. Such comprehensive diagnostic approaches are essential for effective veterinary care and the overall health management of animal populations.
MARKET OVERVIEW:
Driver: Growing awareness regarding animal health is driving the market growth.
The adoption of pets represents a noteworthy trend in the market. People are increasingly opting to bring pets into their homes, primarily for companionship, and there has been a significant shift in the perception of pet ownership towards considering individuals as pet parents rather than mere pet holders. According to the American Pet Products Association (APPA) in 2019, approximately 67% of households in the United States owned at least one pet. This substantial increase in the population of pet owners is serving as a key driver for the growth of the veterinary health market. As more individuals embrace the role of pet parents, there is a corresponding surge in the demand for veterinary services, healthcare products, and diagnostics to ensure the well-being of their animal companions. This shift in attitudes towards pets is influencing the dynamics of the veterinary health market, creating opportunities for growth and development in response to the evolving needs of pet owners.
Opportunities: Public-private partnerships for animal health is expected to pave the way for next generation optical fiber market growth in the upcoming years.
The increasing demand for animal care products is fueled by the reinforcement of public-private partnerships. Growing awareness and improved accessibility to these products are key contributors to the rising demand. The 2017 survey by the OIE-World Organization of Animal Health underscores the potential impact of Public-Private Partnerships (PPPs) in elevating the quality of veterinary services worldwide. This potential arises from the reorganization of dynamic and sustainable systems, ultimately making significant contributions to the health and well-being of human populations.
COVID IMPACT:
The animal diagnostics industry experienced a positive impact from the COVID-19 pandemic, with a significant increase in the adoption of pets and the use of animal diagnostic test kits. Despite this surge, temporary closures of veterinary units during lockdowns posed constraints in certain market segments. Notably, the demand for effective COVID-19 care for animals rose during this period, acknowledging their susceptibility to the disease. The University of Glasgow played a pioneering role in identifying the presence of COVID-19 infection among various pets, including cats, dogs, and other animals.
SEGMENTATION ANALYSIS:
The immunodiagnostics is anticipated to grow significantly during the forecast period.
The immunodiagnostics segment is anticipated to surpass USD 8 billion by 2032, driven by the increasing occurrences of zoonotic diseases in livestock. Common zoonoses affecting farm animals include viral respiratory tract infections, leptospirosis, bovine ephemeral fever, infectious bovine rhinotracheitis, and Johne's disease. According to the World Health Organization (WHO), approximately 1 billion cases of death and illness occur annually globally due to zoonoses. This underscores the critical need for advanced animal diagnostics among farmers to safeguard their investments in livestock. Immunodiagnostics plays a crucial role as it enables veterinarians to detect various autoimmune diseases, making it indispensable to the cause.
The hospital segment is anticipated to grow significantly during the forecast period.
In 2018, the largest share in the market was held by the hospitals & clinics segment. The growth of this segment was facilitated by the increasing number of pet hospitals and clinics, coupled with growing awareness about the spread of zoonotic diseases. Over the forecast period, the diagnostic centers segment is expected to experience rapid growth, driven by an increasing awareness among pet owners about the welfare and importance of preventive care for their companion animals. Furthermore, the market is being propelled by the introduction of molecular diagnostic tests such as ELISA and PCR, which now constitute a significant portion of animal healthcare practices. These advanced diagnostic techniques contribute to the overall expansion of the market.
REGIONAL ANALYSIS:
The North American region is set to witness significant growth during the forecast period.
In 2022, the North America market for animal diagnostics healthcare claimed the largest share, primarily attributed to various proactive measures implemented by government animal welfare organizations aimed at enhancing overall animal health. Additionally, the market in this region is expected to experience growth due to technological advancements, an elevated incidence of zoonotic diseases, and an increasing number of pet owners. Collaborative initiatives undertaken by major businesses to enhance their research and development capabilities and uphold high-quality standards are anticipated to further boost demand in the region. Moreover, the substantial share can be linked to the high disease burden prevalent in North America.
COMPETITIVE ANALYSIS:
The global Animal Health Diagnosis market is reasonably competitive with mergers, acquisitions, and product launches. See some of the major key players in the market.
Bimeda
In November 2023, Bimeda has opened a new manufacturing facility in China dedicated to sterile injections and parasite-control products, thereby expanding its operational capabilities.
Zoetis
In October 2023, Zoetis has initiated the commercial release of Librela, its anti-NGF monoclonal antibody treatment, in the United States for the management of pain associated with canine osteoarthritis.
Ceva Santé Animale
Merck & Co., Inc.
Vetoquinol S.A.
Boehringer Ingelheim Gmbh
Elanco
Virbac
Mars Inc.
Dechra Pharmaceuticals Plc
Idexx Laboratories, Inc.
SCOPE OF THE REPORT
By Technology
Immunodiagnostics
ELISA
Immunoassay Analyzers
Clinical Biochemistry
Glucose Monitoring
Hematology
Urinalysis
By Application
Parasitology
Pathology
By End Use
Clinics
Hospitals
By Region
North America (the United States & Canada)
Europe (Germany, UK, France, Spain, Italy, and the Rest of Europe)
Asia Pacific (China, Japan, India, and Rest of Asia Pacific)
Rest of the World (the Middle East & Africa, and Latin America)
KEY REASONS TO PURCHASE THIS REPORT
It provides a technological development map over time to understand the industry’s growth rate and indicates how the Animal Health Diagnosis market is evolving.
The report offers a dynamic method to various factors that drive or restrain the growth of the market and specifies which Animal Health Diagnosis submarket will be the main driver of the overall market from 2024 to 2032.
It renders a definite analysis of changing competitive dynamics and stipulates the leading players and what are their prospects over the forecast period.
It builds a nine-year estimate based on how the market is predicted to grow and shows what will market shares of the global region change by 2032 and which country will lead the market in 2032.
Table of Contents
167 Pages
- 1. Executive Summary
- 1.1. Market Snapshot
- 1.2. Regional Analysis
- 1.3. Segment Analysis
- 2. Overview And Scope
- 2.1. Market Vision
- 2.1.1. Market Definition
- 2.2. Market Segmentation
- 3. Global Animal Health Diagnosis Market Overview By Region: 2019 Vs 2023 Vs 2032
- 3.1. Global Animal Health Diagnosis Market Size By Regions (2019-2023) (Usd Million)
- 3.1.1. North America Animal Health Diagnosis Market Size By Country (2019-2023) (Usd Million)
- 3.1.2. Europe Animal Health Diagnosis Market Size By Country (2019-2023) (Usd Million)
- 3.1.3. Asia Pacific America Animal Health Diagnosis Market Size By Country (2019-2023) (Usd Million)
- 3.1.4. Rest Of The World Animal Health Diagnosis Market Size By Country (2019-2023) (Usd Million)
- 3.2. Global Animal Health Diagnosis Market Size By Regions (2024-2032) (Usd Million)
- 3.2.1. North America Animal Health Diagnosis Market Size By Country (2024-2032) (Usd Million)
- 3.2.2. Europe Animal Health Diagnosis Market Size By Country (2024-2032) (Usd Million)
- 3.2.3. Asia Pacific Animal Health Diagnosis Market Size By Country (2024-2032) (Usd Million)
- 3.2.4. Rest Of The World Animal Health Diagnosis Market Size By Country (2024-2032) (Usd Million)
- 4. Global Animal Health Diagnosis Market Dynamics
- 4.1. Market Overview
- 4.1.1. Market Drivers
- 4.1.2. Market Restraints/ Challenges Analysis
- 4.1.3. Market Opportunities
- 4.2. Pestle Analysis
- 4.3. Porter’s Five Forces Model
- 4.3.1. Bargaining Power Of Suppliers
- 4.3.2. Bargaining Power Of Buyers
- 4.3.3. The Threat Of New Entrants
- 4.3.4. Threat Of Substitutes
- 4.3.5. Intensity Of Rivalry
- 4.4. Value Chain Analysis/Supply Chain Analysis
- 4.5. Covid-19 Impact Analysis On Global Animal Health Diagnosis Market
- ** In – Depth Qualitative Analysis Will Be Provided In The Final Report Subject To Market
- 5. Global Animal Health Diagnosis Market, By Technology
- 5.1. Overview
- 5.2. Global Animal Health Diagnosis Market Size By Technology
- 5.3. Key Findings For Animal Health Diagnosis Market - By Technology
- 5.3.1. Immunodiagnostics
- 5.3.2. Elisa
- 5.3.3. Immunoassay Analyzers
- 5.3.4. Clinical Biochemistry
- 5.3.5. Glucose Monitoring
- 5.3.6. Hematology
- 5.3.7. Urinalysis
- 6. Global Animal Health Diagnosis Market, By Application
- 6.1. Overview
- 6.2. Key Findings For Animal Health Diagnosis Market - By Application
- 6.2.1. Parasitology
- 6.2.2. Pathology
- 7. Global Animal Health Diagnosis Market, By End Use
- 7.1. Overview
- 7.2. Key Findings For Animal Health Diagnosis Market - By End Use
- 7.2.1. Clinics
- 7.2.2. Hospitals
- 8. Global Animal Health Diagnosis Market, By Region
- 8.1. Overview
- 8.2. Key Findings For Animal Health Diagnosis Market- By Region
- 8.3. Global Animal Health Diagnosis Market, By Technology
- 8.4. Global Animal Health Diagnosis Market, By Application
- 8.5. Global Animal Health Diagnosis Market, By End Use
- 9. Global Animal Health Diagnosis Market- North America
- 9.1. Overview
- 9.2. North America Animal Health Diagnosis Market Size (2019 - 2032) (Usd Million)
- 9.3. North America Animal Health Diagnosis Market, By Technology
- 9.4. North America Animal Health Diagnosis Market, By Application
- 9.5. North America Animal Health Diagnosis Market, By End Use
- 9.6. North America Animal Health Diagnosis Market Size By Countries
- 9.6.1. United States
- 9.6.2. Canada
- 10. Global Animal Health Diagnosis Market- Europe
- 10.1. Overview
- 10.2. Europe Animal Health Diagnosis Market Size (2019 - 2032) (Usd Million)
- 10.3. Europe Animal Health Diagnosis Market, By Technology
- 10.4. Europe Animal Health Diagnosis Market, By Application
- 10.5. Europe Animal Health Diagnosis Market, By End Use
- 10.6. Europe Animal Health Diagnosis Market Size By Countries
- 10.6.1. Germany
- 10.6.2. Uk
- 10.6.3. France
- 10.6.4. Spain
- 10.6.5. Italy
- 10.6.6. Rest Of Europe
- 11. Global Animal Health Diagnosis Market - Asia Pacific
- 11.1. Overview
- 11.2. Asia Pacific Animal Health Diagnosis Market Size (2019 - 2032) (Usd Million)
- 11.3. Asia Pacific Animal Health Diagnosis Market, By Technology
- 11.4. Asia Pacific Animal Health Diagnosis Market, By Application
- 11.5. Asia Pacific Animal Health Diagnosis Market, By End Use
- 11.6. Asia Pacific Animal Health Diagnosis Market Size By Countries
- 11.6.1. China
- 11.6.2. Japan
- 11.6.3. India
- 11.6.4. Rest Of Asia Pacific
- 12. Global Animal Health Diagnosis Market- Rest Of World
- 12.1. Overview
- 12.2. Rest Of World Animal Health Diagnosis Market Size (2019 - 2032) (Usd Million)
- 12.3. Rest Of World Animal Health Diagnosis Market, By Technology
- 12.4. Rest Of World Animal Health Diagnosis Market, By Application
- 12.5. Rest Of World Animal Health Diagnosis Market, By End Use
- 12.6. Rest Of World Animal Health Diagnosis Market Size By Regions
- 12.6.1. Middle East & Africa
- 12.6.2. Latin America
- 13. Global Animal Health Diagnosis Market- Competitive Landscape
- 13.1. Key Strategies Adopted By The Leading Players
- 13.2. Recent Developments
- 13.2.1. Investments & Expansions
- 13.2.2. New End-user Launches
- 13.2.3. Mergers & Acquisitions
- 13.2.4. Agreements, Joint Ventures, And Partnerships
- 14. Global Animal Health Diagnosis Market- Company Profiles
- 14.1. Bimeda
- 14.1.1. Company Overview
- 14.1.2. Financial Overview
- 14.1.3. Product Offered
- 14.1.4. Key Developments
- 14.2. Zoetis
- 14.3. Ceva Santé Animale
- 14.4. Merck & Co., Inc.
- 14.5. Vetoquinol S.A.
- 14.6. Boehringer Ingelheim Gmbh
- 14.7. Elanco
- 14.8. Virbac
- 14.9. Mars Inc.
- 14.10. Dechra Pharmaceuticals Plc
- 14.11. Idexx Laboratories, Inc.
- 15. Our Research Methodology
- 15.1. Data Triangulation
- 15.2. Data Sources
- 15.2.1. Secondary Sources
- 15.2.2. Primary Sources
- 15.3. Assumptions/ Limitations For The Study
- 15.4. Research & Forecasting Methodology
- 16. Appendix
- 16.1. Disclaimer
- 16.2. Contact Us
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
